Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily Tadalafil as Adjunctive Therapy vs Monotherapy in PDE5 Inhibitor-Resistant Erectile Dysfunction
NCT07753720Phase 4Recruiting
- Sponsor
- Al-Azhar University
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in erectile dysfunction (ED), sponsored by Al-Azhar University. Started Aug 2026; status: recruiting.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07753720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753720.